Archives of Pediatric Infectious Diseases

Published by: Kowsar

The Validity of a Scoring System in Predicting Intravenous Immunoglobulin Treatment Failure in Children With Kawasaki Disease

Alireza Nateghian 1 , * , Roya Isa Tafreshi 1 , Arezoo Najari 2 and Atefeh Vaezi 3
Authors Information
1 Department of Pediatrics, Aliasghar Children Hospital, Iran University of Medical Sciences, Tehran, IR Iran
2 Aliasghar Children Hospital, Iran University of Medical Sciences, Tehran, IR Iran
3 Department of Social Medicine, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: January 01, 2016, 4 (1); e27527
  • Published Online: December 30, 2015
  • Article Type: Research Article
  • Received: February 8, 2015
  • Revised: October 9, 2015
  • Accepted: November 7, 2015
  • DOI: 10.5812/pedinfect.27527

To Cite: Nateghian A, Isa Tafreshi R, Najari A, Vaezi A. The Validity of a Scoring System in Predicting Intravenous Immunoglobulin Treatment Failure in Children With Kawasaki Disease, Arch Pediatr Infect Dis. 2016 ; 4(1):e27527. doi: 10.5812/pedinfect.27527.

Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Tacke CE, Burgner D, Kuipers IM, Kuijpers TW. Management of acute and refractory Kawasaki disease. Expert Rev Anti Infect Ther. 2012; 10(10): 1203-15[DOI][PubMed]
  • 2. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006; 113(22): 2606-12[DOI][PubMed]
  • 3. Seki M, Kobayashi T, Kobayashi T, Morikawa A, Otani T, Takeuchi K, et al. External validation of a risk score to predict intravenous immunoglobulin resistance in patients with kawasaki disease. Pediatr Infect Dis J. 2011; 30(2): 145-7[DOI][PubMed]
  • 4. Cha S, Yoon M, Ahn Y, Han M, Yoon KL. Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease. J Korean Med Sci. 2008; 23(4): 718-22[DOI][PubMed]
  • 5. Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011; 158(5): 831-835000[DOI][PubMed]
  • 6. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatrics International. 2005; 47(2): 232-4[DOI]
  • 7. Sittiwangkul R, Pongprot Y, Silvilairat S, Phornphutkul C. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease. Singapore Med J. 2006; 47(9): 780-4[PubMed]
  • 8. Moffett BS, Syblik D, Denfield S, Altman C, Tejtel-Sexson K. Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database. Pediatr Cardiol. 2015; 36(2): 374-8[DOI][PubMed]
  • 9. Karimi A, Nateghian AR, KARIMI M, Shirvani B. Association Of Cardiovascular Complications With Acute Phase Response In Kawasaki Patients. Sci J Hamedan Uni Med Sci. 2002; 9(3): 17-21
  • 10. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006; 149(2): 237-40[DOI][PubMed]
  • 11. Rigante D, Valentini P, Rizzo D, Leo A, De Rosa G, Onesimo R, et al. Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int. 2010; 30(6): 841-6[DOI][PubMed]
  • 12. Lee SM, Lee JB, Go YB, Song HY, Lee BJ, Kwak JH. Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease. Korean Circ J. 2014; 44(6): 415-22
  • 13. Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2007; 166(2): 131-7[DOI][PubMed]
  • 14. Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Management of Kawasaki disease. Arch Dis Child. 2014; 99(1): 74-83[DOI][PubMed]
  • 15. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008; 153(1): 117-21[DOI][PubMed]
  • 16. Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, et al. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum. 2013; 65(3): 805-14[DOI][PubMed]
  • 17. Shiari R. Kawasaki Disease; A Review Article. Archives of Pediatric Infectious Diseases. 2013; 2(1): 154-9
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments